关于C-myc瘤多样性对固体和淋巴细胞恶性瘤的临床影响
Sotirios Papouliakos1, Aristeidis Chrysovergis2, Vasileios Papanikolaou3
1Department of Otolaryngology,''Gennimatas'' GNA Hospital, Athens, Greece.
Maedica
|August 27, 2024
概括
在固体癌症和血液癌症中,C-myc瘤基因具有明显的放松调节机制. 了解这些差异是针对癌症向治疗的关键.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 恶性瘤的发展涉及遗传和染色体放松调节.
- 在各种癌症中,C-myc原型瘤基因 (基因位点:8q24.21) 经常发生变化.
- 在细胞周期,细胞亡,分化和转化中,C-myc起着至关重要的作用.
研究的目的:
- 调查C-myc在固体和淋巴细胞恶性瘤中的差异性瘤活性.
- 了解C-myc变化如何影响这些癌症的临床结果.
主要方法:
- 使用PubMed数据库进行了系统的文献审查.
- 优先考虑到2010年出版的文章,包括开创性的历史参考文献.
- 关键词包括C-myc,瘤基因,信号通路,恶性瘤,癌症和淋巴瘤.
主要成果:
- 通过放大,突变和转移发生C-myc放松调节.
- 这些变化模式在固体和血液恶性瘤之间有明显的差异.
- C-myc转位可以与放大或突变同时发生,形成独特的遗传特征.
结论:
- 根据恶性瘤的起源组织,C-myc表现出不同的放松调节机制.
- 这种"双相"的C-myc放松调节模型会影响患者的预后.
- 了解这些分子差异对于开发有效的向治疗策略至关重要.
相关概念视频
Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Cancers Originate from Somatic Mutations in a Single Cell
11.8K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.8K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Cancer
48.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.2K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


